Category Archives: Medication

Roundup of Atrial Fibrillation Awareness Month Stories and Resources

Today we have a roundup of Atrial Fibrillation Awareness Month stories for you: In her EP Lab DigestPatient Perspective column for this month, StopAfib.org founder Mellanie True Hills summarized the atrial fibrillation stroke prevention report produced by the Afib Optimal Treatment Task Force. There is a lot of great information for patients in this article. …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Adding Renal Artery Denervation to Atrial Fibrillation Pulmonary Vein Isolation Can Double Success Rates for Afib Patients with High Blood Pressure

Some fascinating new research just reported in the Journal of the American College of Cardiology has shown that atrial fibrillation treatment success more than doubles when patients with medication-resistant high blood pressure [hypertension] and atrial fibrillation have a pulmonary vein isolation catheter ablation augmented by a kidney-related procedure called “renal artery denervation.” To learn more …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Dr. James Reiffel on Atrial Fibrillation Treatments, Including Combining Ranolazine with Dronedarone — Video

At Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms. Watch the …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

New Expert Recommendations on Assessing Atrial Fibrillation Stroke and Bleeding Risk for Appropriate Anticoagulation

The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and …

Read More

Addressing the Atrial Fibrillation Controversy: Rate Control vs. Rhythm Control Treatment for Afib — Video

In this video interview recorded at Heart Rhythm 2012, Dr. Eric Prystowsky tackled the controversial topic of rate control vs. rhythm control for treating atrial fibrillation, and knowing whether you are symptomatic or asymptomatic. He also discussed the issues related to leaving afib patients on rate control long term, such as the buildup of fibrosis …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Why You Shouldn’t Use Aspirin for Atrial Fibrillation Stroke Prevention — Video with Dr. Waldo

At Heart Rhythm 2012, Dr. Albert Waldo shared with StopAfib.org’s Mellanie True Hills about why aspirin should no longer be used for the prevention of stroke in atrial fibrillation. Dr. Waldo noted that many global afib guidelines have been revised, or soon will be, to remove aspirin as a recommended atrial fibrillation stroke prevention treatment. …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Is It Time to Re-think Typical Atrial Fibrillation Treatment?

The wildly beating heart, fatigue and other debilitating symptoms are well known to the many millions of people impacted by atrial fibrillation. Some of those who have afib may have no outward symptoms, but are still at risk of serious and long-term damage to the heart. Symptoms or not, rate control is the common treatment …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Update on Atrial Fibrillation Stroke Prevention — Video interview with Dr. Daniel Singer of Harvard

In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Boston Atrial Fibrillation Symposium 2012 Recap and Notes – Guest Posts by Dr. John Mandrola

Dr. John Mandrola, a cardiac electrophysiologist in Louisville, Kentucky, who blogs at Dr. John M, live-blogged the 2012 Boston Atrial Fibrillation Symposium. He has given us permission to reprint his blog posts for the afib community. You will find them here: Recap of Boston Atrial Fibrillation Symposium 2012 – Guest Posts by Dr. John Mandrola …

Read More